ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 62

Human Gingiva-derived Mesenchymal Stem Cells Are Therapeutic in Lupus Nephritis Through Targeting of CD39-CD73 Signaling Pathway

Song Guo Zheng1, Julie Wang 2, Junlong dang 3, Nancy Olsen 4 and Wael Jarjour 1, 1Ohio State College of Medicine, Columbus, OH, 2Ohio State University, columbus, 3Sun Yat-sen University, Guangzhou, 4Penn State University, Hershey, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: autoimmune diseases, cell therapy and adenosine, Lupus nephritis, Mesenchymal stem cells

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, November 10, 2019

Session Title: SLE – Animal Models Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Cell specific and cytokine targeted therapeutics have underperformed in systemic lupus erythematosus (SLE) in spite of numerous targets examined and clinical trials conducted.  Mesenchymal stem cells (MSCs), especially bone marrow derived MSCs (BMSCs), have emerged as a novel therapy to address the dysregulation in autoimmune diseases because of their immunomodulatory and tissue regeneration properties. Nonetheless, BMSCs have limitations such as heterogeneous cell populations, dysfunction of autologous BMSCs and tumorigenesis. Compared with BMSCs, human gingiva derived MSCs (GMSCs) are superior in regulating immune responses.

Methods: In this study, we prepared gingiva-derived mesenchymal stem cells and adoptively transferred them to NZM2328 mice, a lupus strain that spontaneously develop lupus nephritis with predilection for female mice.

Results: We demonstrate that the adoptively transferred GMSC home to the kidney quickly and have a robust therapeutic effect. Specifically, the administration of GMSCs limits the development of autoantibodies as well as proteinuria, decreases the frequency of plasma cells and lupus nephritis histopathological scores. We further observed that GMSCs directly targeted B cells through suppression of activation and proliferation, plasmocyte differentiation and autoantibody production in an inflammatory milieu.  The blockage of CD39-CD73 pathway dramatically abrogated the suppressive capacities of GMSCs in vitro and in vivo and highlights the significance of this signaling pathway in SLE.

Conclusion: Collectively, manipulation of GMSCs provides a promising strategy for the treatment of patients with SLE and other autoimmune diseases.


Disclosure: S. Zheng, None; J. Wang, None; J. dang, None; N. Olsen, None; W. Jarjour, None.

To cite this abstract in AMA style:

Zheng S, Wang J, dang J, Olsen N, Jarjour W. Human Gingiva-derived Mesenchymal Stem Cells Are Therapeutic in Lupus Nephritis Through Targeting of CD39-CD73 Signaling Pathway [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/human-gingiva-derived-mesenchymal-stem-cells-are-therapeutic-in-lupus-nephritis-through-targeting-of-cd39-cd73-signaling-pathway/. Accessed April 17, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-gingiva-derived-mesenchymal-stem-cells-are-therapeutic-in-lupus-nephritis-through-targeting-of-cd39-cd73-signaling-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.